Effect of Early Everolimus-Facilitated Reduction of Tacrolimus on Efficacy and Renal Function in De Novo Liver Transplant Recipients: 24-Month Results for the North American Subpopulation

BACKGROUND: A recent randomized phase III study of 719 de novo liver transplant recipients showed that early everolimus plus reduced-dose tacrolimus (EVR + rTAC) led to significantly better kidney function than standard TAC (TAC-C), without compromising efficacy. In that study, patients from North A...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Transplantation
Autori principali: Chapman, William C., Brown, Robert S., Chavin, Kenneth D., Sudan, Debra, Koneru, Baburao, Junge, Guido, Dong, Gaohong, Patel, Dharmesh, Teperman, Lewis, Fung, John J.
Natura: Artigo
Lingua:Inglês
Pubblicazione: Lippincott Williams & Wilkins 2017
Soggetti:
Original Clinical Science—Liver
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5265688/
https://ncbi.nlm.nih.gov/pubmed/28121741
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/TP.0000000000001524
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi